SF2071
Step therapy use protocol for insulin drugs prohibition
Legislative Session 94 (2025-2026)
Related bill: HF743
AI Generated Summary
This bill, S.F. No. 2071, introduced in the Minnesota Senate, aims to prohibit the use of step therapy protocols for prescription insulin drugs in health insurance plans.
Key Points of the Bill:
- Definition Section: It defines diabetes (including type I, type II, and gestational), prescription insulin drugs, and step therapy protocol based on existing statutes.
- Prohibition on Step Therapy for Insulin: Health insurance plans that cover diabetes treatment cannot require patients to follow step therapy protocols for insulin prescriptions.
- Step therapy is a cost-control process where patients must try and fail on lower-cost medications before insurers cover a more expensive prescribed drug.
- Step therapy is a cost-control process where patients must try and fail on lower-cost medications before insurers cover a more expensive prescribed drug.
Impact:
If enacted, this bill would ensure that Minnesota residents with diabetes can access physician-prescribed insulin without first trying alternative medications, preventing potential delays in necessary treatment.
Past committee meetings
You must be logged in to view 1 past legislative committee meetings.
Actions
| Date | Chamber | Where | Type | Name | Committee Name |
|---|---|---|---|---|---|
| March 03, 2025 | Senate | Action | Introduction and first reading | ||
| March 03, 2025 | Senate | Action | Referred to | Commerce and Consumer Protection | |
| March 06, 2025 | Senate | Action | Author added | ||
| March 09, 2026 | Senate | Action | Comm report: To pass and re-referred to | Health and Human Services | |
| Showing the 5 most recent stages. This bill has 4 stages in total. Log in to view all stages | |||||
Progress through the legislative process
In Committee
Sponsors
You must be logged in to view sponsors.